Quest Diagnostics Incorporated DGX
236.32
(0.27)
(0.11%)
as of 25 Sep
- Market cap
- $26.2B
- P/E
- 24.8×
Follow DGX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Quest Diagnostics Incorporated (DGX) Return on equity
Quest Diagnostics Incorporated's return on equity over the twelve months to 30 June 2026 was 14.0%, down 0.1 percentage points from fiscal 2025 (14.1%). Over the past ten years it has ranged from 13.2% (fiscal 2024) to 29.9% (fiscal 2021); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of −2.92% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 14.1% | 0.93 |
| FY2024 | 13.2% | (0.68) |
| FY2023 | 13.9% | (1.33) |
| FY2022 | 15.2% | (14.73) |
| FY2021 | 29.9% | 7.10 |
| FY2020 | 22.8% | 7.14 |
| FY2019 | 15.7% | 1.27 |
| FY2018 | 14.4% | (1.66) |
| FY2017 | 16.1% | 2.36 |
| FY2016 | 13.7% | (1.91) |
Against its own ten years
Low 13.2%
High 29.9%
Ten-year median
15.2%
Current reading's percentile
36
Return on equity against peers
| Company | Return on equity |
|---|---|
| GH Guardant Health, Inc. compare | 171.6% |
| MEDP Medpace Holdings, Inc. compare | 162.2% |
| IDXX IDEXX Laboratories, Inc. compare | 74.2% |
| ILMN Illumina, Inc. compare | 32.4% |
| DGX Quest Diagnostics Incorporated | 14.0% |
| LH Labcorp Holdings Inc. compare | 11.7% |
| RVTY Revvity Inc. compare | 3.21% |
| WAT Waters Corporation compare | 1.92% |
| MTD Mettler-Toledo International, Inc. compare | −736.4% |
| Diagnostics & Research industry median | −2.92% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on DGX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement